Ann Lab Med.  2019 Mar;39(2):121-124. 10.3343/alm.2019.39.2.121.

Reducing Diagnostic Errors Worldwide Through Diagnostic Management Teams

• Verna R
• Velazquez
• Laposata M

• KMID: 2425966
• DOI: http://doi.org/10.3343/alm.2019.39.2.121

Abstract

A major challenge facing most countries is the growing cost of healthcare. Laboratory testing costs constitute approximately 3% of all clinical costs, while waste of funds due to inappropriate admissions to clinical departments is reported to be as high as 15%. A frequently used approach to save money in healthcare is random reduction of laboratory budgets, focusing on decreasing the number of unnecessary laboratory tests. The World Health Assembly has approached this problem by publishing a list of essential in vitro diagnostic tests, to achieve a global rationalization of the problem. A much more thoughtful strategy to reducing healthcare expenditure is to improve the efficiency of the diagnostic process. Decreasing the time to a correct diagnosis provides considerable financial and clinical benefits. Additionally, reducing both overutilization and underutilization of laboratory tests while achieving the correct diagnosis is of great benefit to challenged healthcare budgets. Examining the situation in the United States and Italy, this review presents an opportunity for reducing diagnostic error and increasing the efficiency of diagnostic testing worldwide. One approach taken to achieve major savings in healthcare in the United States, which can be applied in Italy and other countries, is the creation of "diagnostic management teams," comprising experts in specialty areas of medicine, primarily based in the clinical laboratory, who can advise physicians on the selection of necessary tests and the interpretation of complex test results.

Keyword

Diagnosis; Diagnostic error; Clinical laboratory; Diagnostic management team

MeSH Terms

Budgets
Delivery of Health Care
Diagnosis
Diagnostic Errors*
Diagnostic Tests, Routine
Financial Management
Global Health
Health Expenditures
In Vitro Techniques
Income
Italy
Rationalization
United States

Figure

• 

  Fig. 1 Current primary care doctor and consultant roles in making a diagnosis.

Reference

1. Essue BM, Laba M, et al. Economic burden of chronic ill health and injuries for households in low- and middle-income countries. In : Jamison DT, Gelband H, editors. Disease control priorities: improving health and reducing poverty. 3rd ed. Washington (DC): The International Bank for Reconstruction and Development/The World Bank;2017. p. 121–146.

2. World Health Organization. World Health Organization model list of essential in vitro diagnostics. 1st ed. Updated on Jun 2018. http://www.who.int/medical_devices/diagnostics/WHO_EDL_2018.pdf.

3. World Health Organization. Selection, access and use of in vitro diagnostics. Updated on Jun 2018. http://www.who.int/medical_devices/diagnostics/Selection_in-vitro_diagnostics/en/.

4. Institute of Medicine (US) Committee on Quality of Health Care in America. Kohn LT, editor. To err is human: building a safer health system. Washington, DC: The National Academies Press;2000. p. 1–312.

5. Hallworth MJ. The “70% claim”: what is the evidence? Ann Clin Biochem. 2011; 48:487–488. PMID: 22045648.

6. Daly AK. Pharmacogenetics: a general review on progress to date. Br Med Bull. 2017; 124:65–79. PMID: 29040422.

7. Hickner J, Thompson PJ, Wilkinson T, Epner P, Sheehan M, Pollock AM, et al. Primary care physicians' challenges in ordering clinical laboratory tests and interpreting results. J Am Board Fam Med. 2014; 27:268–274. PMID: 24610189.

8. Committee on Diagnostic Error in Healthcare. Board on Health Care Services. . Improving diagnosis in health care. Washington, DC: National Academies Press;2015. p. 1–472.

9. Bindraban RS, Ten Berg MJ, Naaktgeboren CA, Kramer MHH, Van Solinge WW, Nanayakkara PWB. Reducing test utilization in hospital settings: a narrative review. Ann Lab Med. 2018; 38:402–412. PMID: 29797809.

10. Laposata M. Obtaining a correct diagnosis rapidly in the United States is associated with many barriers not present in other countries. Am J Clin Pathol. 2018; 149:458–460. PMID: 29635278.

11. Smith BR, Kamoun M, Hickner J. Laboratory medicine education at U.S. medical schools: a 2014 status report. Acad Med. 2016; 91:107–112. PMID: 26200574.

12. Tettamanti M, Lucca U, Gandini F, Recchia A, Mosconi P, Apolone G, et al. Prevalence, incidence, and types of mild anemia in the elderly: The “Health and Anemia” population-based study. Haematologica. 2010; 95:1849–1856. PMID: 20534701.

13. Seegmiller AC, Kim AS, Mosse CA, Levy MA, Thompson MA, Jagasia MH, et al. Optimizing personalized bone marrow testing using an evidence-based, interdisciplinary team approach. Am J Clin Pathol. 2013; 140:643–650. PMID: 24124142.

14. Laposata M, Dighe A. “Pre-pre” and “post-post” analytic error: high-incidence patient safety hazards involving the clinical laboratory. Clin Chem Lab Med. 2007; 45:712–719. PMID: 17579522.

15. Laposata ME, Laposata M, Van Cott EM, Buchner DS, Kashalo MS, Dighe AS. Physician survey of a laboratory medicine interpretive service and evaluation of the influence of interpretations on laboratory test ordering. Arch Pathol Lab Med. 2004; 128:1424–1427. PMID: 15578888.

16. Aquino AC. How to spot the savings from a diagnostic management team. CAP Today;2017. 10. Online version available at http://captodayonline.com/spot-savings-diagnostic-team/.

17. University of Texas Medical Branch. DMTConference.com 2017 and 2018. https://www.dmtconference.com/.